SEC Form 4 · accession 0001078782-17-000855
Zivo Bioscience, Inc. · ZIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher D. Maggiore
Director · 10% Owner
Period of report
May 7, 2017
Accepted (ET)
Jun 14, 2017 · 2:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001101026
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 7, 2017 | P | 44,000 | $0.067 | A | 13,542,831 | D | |
| Common Stock | May 8, 2017 | P | 30,000 | $0.071 | A | 13,572,831 | D | |
| Common Stock | May 12, 2017 | P | 10,000 | $0.07 | A | 13,582,831 | D |
Table II — derivative securities
No Table II lines on this filing.